JOSHUA CLARK: Open Payments
NPI 1184913493 · PLAQUEMINE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 33 payments from 13 companies in 2025. Trend: 2023 $259 · 2024 $0 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $94 |
| Lundbeck LLC | 4 | $81 |
| ABBVIE INC. | 4 | $77 |
| Exact Sciences Corporation | 4 | $63 |
| Novo Nordisk Inc | 4 | $58 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: REXULTI, MOUNJARO, The Cologuard Plus Collection Kit, Auvelity, VOQUEZNA, UBRELVY, Ozempic, ZEPBOUND.
Industry payments across LA — which companies pay providers there.
